NCT06088160 Changes in Postural Stability Following THA for OA
| NCT ID | NCT06088160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western University, Canada |
| Condition | Osteoarthritis, Hip |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-12-27 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-12-27 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total hip arthroplasty (THA) is a common surgery that eases pain, restores functional movement, and improves the overall quality of life in people with severe hip osteoarthritis (OA). Unfortunately, problems with postural stability, commonly known as balance, are still noticed in people even years after the surgery. These postural stability problems typically result in falls. The aim of the proposed study is to investigate how THA surgery affects a person's overall quality of life, both physically and psychologically, in terms of postural stability and balance confidence (self-efficacy) within the first three months after THA for osteoarthritis. This prospective cohort study will focus on people over 60 years old.
Eligibility Criteria
Inclusion Criteria: * ≥ 60 years of age, scheduled to receive an elective unilateral THA (DA or DL approach) for OA * Ambulatory for a minimum of 10 meters with or without a mobility aid but without the assistance of another person * Able to read, write and speak English * Able to provide consent Exclusion Criteria: * Bilateral THA * Underwent THA surgery for a diagnosis other than OA * Any condition that will prevent participants from completing the study such as having a significant neurological, cardiovascular, musculoskeletal condition as denoted by their physician.
Contact & Investigator
Brent Lanting, MD
PRINCIPAL INVESTIGATOR
London Health Sciences Centre
Frequently Asked Questions
Who can join the NCT06088160 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Osteoarthritis, Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06088160 currently recruiting?
Yes, NCT06088160 is actively recruiting participants. Contact the research team at tony.adebero@lhsc.on.ca for enrollment information.
Where is the NCT06088160 trial being conducted?
This trial is being conducted at London, Canada.
Who is sponsoring the NCT06088160 clinical trial?
NCT06088160 is sponsored by Western University, Canada. The principal investigator is Brent Lanting, MD at London Health Sciences Centre. The trial plans to enroll 80 participants.